nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—panic disorder—Diazepam—epilepsy syndrome	0.134	0.425	CpDpCtD
Fluvoxamine—endogenous depression—Valproic Acid—epilepsy syndrome	0.0997	0.317	CpDpCtD
Fluvoxamine—panic disorder—Clonazepam—epilepsy syndrome	0.081	0.258	CpDpCtD
Fluvoxamine—SLC6A4—epilepsy syndrome	0.0583	0.317	CbGaD
Fluvoxamine—CYP2C19—epilepsy syndrome	0.0553	0.301	CbGaD
Fluvoxamine—CYP2D6—epilepsy syndrome	0.041	0.223	CbGaD
Fluvoxamine—ABCB1—epilepsy syndrome	0.0293	0.159	CbGaD
Fluvoxamine—CYP2E1—Felbamate—epilepsy syndrome	0.00807	0.0247	CbGbCtD
Fluvoxamine—CYP2E1—Trimethadione—epilepsy syndrome	0.00807	0.0247	CbGbCtD
Fluvoxamine—CYP2B6—Fosphenytoin—epilepsy syndrome	0.00749	0.0229	CbGbCtD
Fluvoxamine—CYP2E1—Clonazepam—epilepsy syndrome	0.00686	0.021	CbGbCtD
Fluvoxamine—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.00675	0.0207	CbGbCtD
Fluvoxamine—CYP2B6—Clobazam—epilepsy syndrome	0.00649	0.0199	CbGbCtD
Fluvoxamine—CYP1A1—Propofol—epilepsy syndrome	0.00591	0.0181	CbGbCtD
Fluvoxamine—CYP3A7—Carbamazepine—epilepsy syndrome	0.00565	0.0173	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.00565	0.0173	CbGbCtD
Fluvoxamine—CYP1A1—Phenobarbital—epilepsy syndrome	0.00564	0.0173	CbGbCtD
Fluvoxamine—CYP2E1—Rufinamide—epilepsy syndrome	0.0056	0.0171	CbGbCtD
Fluvoxamine—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00544	0.0167	CbGbCtD
Fluvoxamine—CYP2B6—Carbamazepine—epilepsy syndrome	0.00538	0.0165	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.00507	0.0155	CbGbCtD
Fluvoxamine—CYP3A7—Phenytoin—epilepsy syndrome	0.00507	0.0155	CbGbCtD
Fluvoxamine—CYP2C19—Felbamate—epilepsy syndrome	0.00506	0.0155	CbGbCtD
Fluvoxamine—CYP2C19—Trimethadione—epilepsy syndrome	0.00506	0.0155	CbGbCtD
Fluvoxamine—CYP2B6—Primidone—epilepsy syndrome	0.00502	0.0154	CbGbCtD
Fluvoxamine—CYP2B6—Phenytoin—epilepsy syndrome	0.00482	0.0148	CbGbCtD
Fluvoxamine—ABCB1—Levetiracetam—epilepsy syndrome	0.0048	0.0147	CbGbCtD
Fluvoxamine—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00476	0.0146	CbGbCtD
Fluvoxamine—CYP2E1—Propofol—epilepsy syndrome	0.00456	0.014	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.00452	0.0138	CbGbCtD
Fluvoxamine—CYP3A7—Phenobarbital—epilepsy syndrome	0.00452	0.0138	CbGbCtD
Fluvoxamine—CYP2B6—Propofol—epilepsy syndrome	0.0045	0.0138	CbGbCtD
Fluvoxamine—CYP3A7—Midazolam—epilepsy syndrome	0.00445	0.0136	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.00445	0.0136	CbGbCtD
Fluvoxamine—CYP2E1—Phenobarbital—epilepsy syndrome	0.00436	0.0134	CbGbCtD
Fluvoxamine—CYP2B6—Phenobarbital—epilepsy syndrome	0.0043	0.0132	CbGbCtD
Fluvoxamine—CYP2E1—Midazolam—epilepsy syndrome	0.0043	0.0132	CbGbCtD
Fluvoxamine—CYP3A7—Diazepam—epilepsy syndrome	0.00428	0.0131	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.00428	0.0131	CbGbCtD
Fluvoxamine—CYP2B6—Midazolam—epilepsy syndrome	0.00424	0.013	CbGbCtD
Fluvoxamine—CYP3A5—Carbamazepine—epilepsy syndrome	0.00424	0.013	CbGbCtD
Fluvoxamine—CYP2C9—Trimethadione—epilepsy syndrome	0.00421	0.0129	CbGbCtD
Fluvoxamine—CYP2E1—Diazepam—epilepsy syndrome	0.00413	0.0127	CbGbCtD
Fluvoxamine—CYP2C19—Clobazam—epilepsy syndrome	0.00412	0.0126	CbGbCtD
Fluvoxamine—CYP2B6—Diazepam—epilepsy syndrome	0.00408	0.0125	CbGbCtD
Fluvoxamine—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00396	0.0121	CbGbCtD
Fluvoxamine—CYP3A5—Phenytoin—epilepsy syndrome	0.0038	0.0116	CbGbCtD
Fluvoxamine—CYP2C19—Carbamazepine—epilepsy syndrome	0.00342	0.0105	CbGbCtD
Fluvoxamine—CYP3A5—Phenobarbital—epilepsy syndrome	0.00339	0.0104	CbGbCtD
Fluvoxamine—CYP3A5—Midazolam—epilepsy syndrome	0.00334	0.0102	CbGbCtD
Fluvoxamine—ABCB1—Clobazam—epilepsy syndrome	0.00333	0.0102	CbGbCtD
Fluvoxamine—CYP2B6—Valproic Acid—epilepsy syndrome	0.00321	0.00985	CbGbCtD
Fluvoxamine—CYP3A5—Diazepam—epilepsy syndrome	0.00321	0.00984	CbGbCtD
Fluvoxamine—ABCB1—Lamotrigine—epilepsy syndrome	0.0032	0.00982	CbGbCtD
Fluvoxamine—CYP2C19—Primidone—epilepsy syndrome	0.00319	0.00978	CbGbCtD
Fluvoxamine—CYP1A2—Carbamazepine—epilepsy syndrome	0.00315	0.00966	CbGbCtD
Fluvoxamine—CYP2C19—Phenytoin—epilepsy syndrome	0.00307	0.00939	CbGbCtD
Fluvoxamine—CYP1A2—Primidone—epilepsy syndrome	0.00294	0.00902	CbGbCtD
Fluvoxamine—CYP2C19—Propofol—epilepsy syndrome	0.00286	0.00876	CbGbCtD
Fluvoxamine—CYP2C9—Carbamazepine—epilepsy syndrome	0.00284	0.00871	CbGbCtD
Fluvoxamine—ABCB1—Carbamazepine—epilepsy syndrome	0.00276	0.00845	CbGbCtD
Fluvoxamine—CYP2C19—Phenobarbital—epilepsy syndrome	0.00273	0.00837	CbGbCtD
Fluvoxamine—CYP2C9—Primidone—epilepsy syndrome	0.00265	0.00813	CbGbCtD
Fluvoxamine—CYP1A2—Propofol—epilepsy syndrome	0.00264	0.00808	CbGbCtD
Fluvoxamine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00263	0.00806	CbGbCtD
Fluvoxamine—CYP2C19—Diazepam—epilepsy syndrome	0.00259	0.00794	CbGbCtD
Fluvoxamine—CYP2C9—Phenytoin—epilepsy syndrome	0.00255	0.00781	CbGbCtD
Fluvoxamine—CYP3A5—Valproic Acid—epilepsy syndrome	0.00253	0.00776	CbGbCtD
Fluvoxamine—CYP2C19—Zonisamide—epilepsy syndrome	0.00253	0.00775	CbGbCtD
Fluvoxamine—CYP1A2—Phenobarbital—epilepsy syndrome	0.00252	0.00773	CbGbCtD
Fluvoxamine—ABCB1—Phenytoin—epilepsy syndrome	0.00247	0.00758	CbGbCtD
Fluvoxamine—CYP3A4—Felbamate—epilepsy syndrome	0.00245	0.0075	CbGbCtD
Fluvoxamine—CYP3A4—Trimethadione—epilepsy syndrome	0.00245	0.0075	CbGbCtD
Fluvoxamine—CYP1A2—Diazepam—epilepsy syndrome	0.00239	0.00732	CbGbCtD
Fluvoxamine—CYP2C9—Propofol—epilepsy syndrome	0.00238	0.00728	CbGbCtD
Fluvoxamine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0023	0.00705	CbGbCtD
Fluvoxamine—CYP2C9—Phenobarbital—epilepsy syndrome	0.00227	0.00696	CbGbCtD
Fluvoxamine—ABCB1—Phenobarbital—epilepsy syndrome	0.0022	0.00676	CbGbCtD
Fluvoxamine—ABCB1—Midazolam—epilepsy syndrome	0.00217	0.00666	CbGbCtD
Fluvoxamine—CYP2D6—Propofol—epilepsy syndrome	0.00217	0.00666	CbGbCtD
Fluvoxamine—CYP2C9—Diazepam—epilepsy syndrome	0.00215	0.0066	CbGbCtD
Fluvoxamine—ABCB1—Diazepam—epilepsy syndrome	0.00209	0.0064	CbGbCtD
Fluvoxamine—CYP3A4—Clonazepam—epilepsy syndrome	0.00208	0.00637	CbGbCtD
Fluvoxamine—CYP2C19—Valproic Acid—epilepsy syndrome	0.00204	0.00626	CbGbCtD
Fluvoxamine—CYP3A4—Clobazam—epilepsy syndrome	0.00199	0.00611	CbGbCtD
Fluvoxamine—CYP1A2—Valproic Acid—epilepsy syndrome	0.00188	0.00577	CbGbCtD
Fluvoxamine—CYP2C19—Topiramate—epilepsy syndrome	0.00184	0.00565	CbGbCtD
Fluvoxamine—CYP2C9—Valproic Acid—epilepsy syndrome	0.0017	0.0052	CbGbCtD
Fluvoxamine—CYP3A4—Rufinamide—epilepsy syndrome	0.0017	0.0052	CbGbCtD
Fluvoxamine—CYP3A4—Carbamazepine—epilepsy syndrome	0.00165	0.00506	CbGbCtD
Fluvoxamine—CYP3A4—Primidone—epilepsy syndrome	0.00154	0.00473	CbGbCtD
Fluvoxamine—CYP3A4—Phenytoin—epilepsy syndrome	0.00148	0.00454	CbGbCtD
Fluvoxamine—CYP3A4—Propofol—epilepsy syndrome	0.00138	0.00424	CbGbCtD
Fluvoxamine—CYP3A4—Acetazolamide—epilepsy syndrome	0.00132	0.00405	CbGbCtD
Fluvoxamine—CYP3A4—Phenobarbital—epilepsy syndrome	0.00132	0.00405	CbGbCtD
Fluvoxamine—CYP3A4—Midazolam—epilepsy syndrome	0.0013	0.00399	CbGbCtD
Fluvoxamine—CYP3A4—Diazepam—epilepsy syndrome	0.00125	0.00384	CbGbCtD
Fluvoxamine—CYP3A4—Zonisamide—epilepsy syndrome	0.00122	0.00375	CbGbCtD
Fluvoxamine—CYP3A4—Valproic Acid—epilepsy syndrome	0.000987	0.00303	CbGbCtD
Fluvoxamine—SLC6A3—telencephalic ventricle—epilepsy syndrome	0.000911	0.0983	CbGeAlD
Fluvoxamine—CYP3A4—Topiramate—epilepsy syndrome	0.000891	0.00273	CbGbCtD
Fluvoxamine—SLC6A3—ganglion—epilepsy syndrome	0.000567	0.0612	CbGeAlD
Fluvoxamine—SLC6A4—ganglion—epilepsy syndrome	0.00052	0.0561	CbGeAlD
Fluvoxamine—SLC6A3—hindbrain—epilepsy syndrome	0.00043	0.0464	CbGeAlD
Fluvoxamine—SLC6A4—hindbrain—epilepsy syndrome	0.000394	0.0425	CbGeAlD
Fluvoxamine—SLC6A3—brainstem—epilepsy syndrome	0.000247	0.0266	CbGeAlD
Fluvoxamine—SLC6A3—forebrain—epilepsy syndrome	0.000238	0.0257	CbGeAlD
Fluvoxamine—SLC6A4—brainstem—epilepsy syndrome	0.000226	0.0244	CbGeAlD
Fluvoxamine—SLC6A3—telencephalon—epilepsy syndrome	0.000219	0.0236	CbGeAlD
Fluvoxamine—SLC6A4—forebrain—epilepsy syndrome	0.000218	0.0235	CbGeAlD
Fluvoxamine—SLC6A4—telencephalon—epilepsy syndrome	0.000201	0.0216	CbGeAlD
Fluvoxamine—SIGMAR1—telencephalon—epilepsy syndrome	0.000199	0.0215	CbGeAlD
Fluvoxamine—CYP2D6—hindbrain—epilepsy syndrome	0.00019	0.0205	CbGeAlD
Fluvoxamine—SLC6A3—midbrain—epilepsy syndrome	0.000157	0.0169	CbGeAlD
Fluvoxamine—SIGMAR1—medulla oblongata—epilepsy syndrome	0.000157	0.0169	CbGeAlD
Fluvoxamine—SLC6A3—spinal cord—epilepsy syndrome	0.000153	0.0165	CbGeAlD
Fluvoxamine—SLC6A4—midbrain—epilepsy syndrome	0.000144	0.0155	CbGeAlD
Fluvoxamine—SIGMAR1—midbrain—epilepsy syndrome	0.000143	0.0154	CbGeAlD
Fluvoxamine—SLC6A4—spinal cord—epilepsy syndrome	0.000141	0.0152	CbGeAlD
Fluvoxamine—SIGMAR1—spinal cord—epilepsy syndrome	0.00014	0.015	CbGeAlD
Fluvoxamine—SLC6A3—head—epilepsy syndrome	0.000136	0.0147	CbGeAlD
Fluvoxamine—SLC6A3—nervous system—epilepsy syndrome	0.000129	0.0139	CbGeAlD
Fluvoxamine—SLC6A4—head—epilepsy syndrome	0.000125	0.0135	CbGeAlD
Fluvoxamine—SLC6A3—central nervous system—epilepsy syndrome	0.000124	0.0134	CbGeAlD
Fluvoxamine—CYP2E1—telencephalon—epilepsy syndrome	0.000122	0.0132	CbGeAlD
Fluvoxamine—SLC6A3—cerebellum—epilepsy syndrome	0.000122	0.0131	CbGeAlD
Fluvoxamine—SLC6A4—nervous system—epilepsy syndrome	0.000118	0.0128	CbGeAlD
Fluvoxamine—SLC6A4—central nervous system—epilepsy syndrome	0.000114	0.0123	CbGeAlD
Fluvoxamine—SIGMAR1—cerebellum—epilepsy syndrome	0.000111	0.0119	CbGeAlD
Fluvoxamine—CYP2D6—brainstem—epilepsy syndrome	0.000109	0.0117	CbGeAlD
Fluvoxamine—CYP2D6—forebrain—epilepsy syndrome	0.000105	0.0113	CbGeAlD
Fluvoxamine—SLC6A3—brain—epilepsy syndrome	9.88e-05	0.0106	CbGeAlD
Fluvoxamine—CYP2D6—telencephalon—epilepsy syndrome	9.67e-05	0.0104	CbGeAlD
Fluvoxamine—CYP2E1—medulla oblongata—epilepsy syndrome	9.59e-05	0.0103	CbGeAlD
Fluvoxamine—SLC6A4—brain—epilepsy syndrome	9.05e-05	0.00976	CbGeAlD
Fluvoxamine—SIGMAR1—brain—epilepsy syndrome	8.99e-05	0.00969	CbGeAlD
Fluvoxamine—CYP2E1—spinal cord—epilepsy syndrome	8.56e-05	0.00922	CbGeAlD
Fluvoxamine—CYP1A1—head—epilepsy syndrome	8.34e-05	0.00899	CbGeAlD
Fluvoxamine—CYP2B6—head—epilepsy syndrome	8.1e-05	0.00874	CbGeAlD
Fluvoxamine—CYP1A1—nervous system—epilepsy syndrome	7.9e-05	0.00852	CbGeAlD
Fluvoxamine—CYP2B6—nervous system—epilepsy syndrome	7.68e-05	0.00828	CbGeAlD
Fluvoxamine—CYP1A1—central nervous system—epilepsy syndrome	7.61e-05	0.00821	CbGeAlD
Fluvoxamine—CYP2E1—head—epilepsy syndrome	7.6e-05	0.0082	CbGeAlD
Fluvoxamine—ABCB1—forebrain—epilepsy syndrome	7.56e-05	0.00816	CbGeAlD
Fluvoxamine—CYP2B6—central nervous system—epilepsy syndrome	7.4e-05	0.00797	CbGeAlD
Fluvoxamine—CYP2E1—nervous system—epilepsy syndrome	7.21e-05	0.00777	CbGeAlD
Fluvoxamine—ABCB1—telencephalon—epilepsy syndrome	6.95e-05	0.0075	CbGeAlD
Fluvoxamine—CYP2E1—central nervous system—epilepsy syndrome	6.94e-05	0.00748	CbGeAlD
Fluvoxamine—CYP2E1—cerebellum—epilepsy syndrome	6.78e-05	0.00731	CbGeAlD
Fluvoxamine—CYP1A1—brain—epilepsy syndrome	6.04e-05	0.00651	CbGeAlD
Fluvoxamine—CYP2D6—head—epilepsy syndrome	6.02e-05	0.00649	CbGeAlD
Fluvoxamine—CYP2B6—brain—epilepsy syndrome	5.87e-05	0.00633	CbGeAlD
Fluvoxamine—CYP3A4—nervous system—epilepsy syndrome	5.8e-05	0.00625	CbGeAlD
Fluvoxamine—CYP2D6—nervous system—epilepsy syndrome	5.71e-05	0.00615	CbGeAlD
Fluvoxamine—CYP3A4—central nervous system—epilepsy syndrome	5.58e-05	0.00602	CbGeAlD
Fluvoxamine—CYP2E1—brain—epilepsy syndrome	5.51e-05	0.00594	CbGeAlD
Fluvoxamine—CYP2D6—central nervous system—epilepsy syndrome	5.5e-05	0.00593	CbGeAlD
Fluvoxamine—ABCB1—medulla oblongata—epilepsy syndrome	5.46e-05	0.00589	CbGeAlD
Fluvoxamine—CYP2D6—cerebellum—epilepsy syndrome	5.37e-05	0.00579	CbGeAlD
Fluvoxamine—ABCB1—midbrain—epilepsy syndrome	4.99e-05	0.00539	CbGeAlD
Fluvoxamine—ABCB1—spinal cord—epilepsy syndrome	4.87e-05	0.00525	CbGeAlD
Fluvoxamine—CYP2D6—brain—epilepsy syndrome	4.36e-05	0.0047	CbGeAlD
Fluvoxamine—ABCB1—head—epilepsy syndrome	4.33e-05	0.00467	CbGeAlD
Fluvoxamine—ABCB1—nervous system—epilepsy syndrome	4.11e-05	0.00443	CbGeAlD
Fluvoxamine—ABCB1—central nervous system—epilepsy syndrome	3.95e-05	0.00426	CbGeAlD
Fluvoxamine—ABCB1—cerebellum—epilepsy syndrome	3.86e-05	0.00417	CbGeAlD
Fluvoxamine—ABCB1—brain—epilepsy syndrome	3.14e-05	0.00338	CbGeAlD
Fluvoxamine—Arthralgia—Pregabalin—epilepsy syndrome	1.05e-05	7.85e-05	CcSEcCtD
Fluvoxamine—Myalgia—Pregabalin—epilepsy syndrome	1.05e-05	7.85e-05	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Gabapentin—epilepsy syndrome	1.05e-05	7.85e-05	CcSEcCtD
Fluvoxamine—Dizziness—Zonisamide—epilepsy syndrome	1.05e-05	7.85e-05	CcSEcCtD
Fluvoxamine—Headache—Diazepam—epilepsy syndrome	1.05e-05	7.85e-05	CcSEcCtD
Fluvoxamine—Anxiety—Pregabalin—epilepsy syndrome	1.04e-05	7.83e-05	CcSEcCtD
Fluvoxamine—Diarrhoea—Clonazepam—epilepsy syndrome	1.04e-05	7.82e-05	CcSEcCtD
Fluvoxamine—Anaemia—Gabapentin—epilepsy syndrome	1.04e-05	7.82e-05	CcSEcCtD
Fluvoxamine—Hypotension—Valproic Acid—epilepsy syndrome	1.04e-05	7.78e-05	CcSEcCtD
Fluvoxamine—Asthenia—Carbamazepine—epilepsy syndrome	1.04e-05	7.78e-05	CcSEcCtD
Fluvoxamine—Agitation—Gabapentin—epilepsy syndrome	1.04e-05	7.77e-05	CcSEcCtD
Fluvoxamine—Diarrhoea—Phenytoin—epilepsy syndrome	1.04e-05	7.77e-05	CcSEcCtD
Fluvoxamine—Discomfort—Pregabalin—epilepsy syndrome	1.03e-05	7.76e-05	CcSEcCtD
Fluvoxamine—Nausea—Fosphenytoin—epilepsy syndrome	1.03e-05	7.75e-05	CcSEcCtD
Fluvoxamine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	1.03e-05	7.73e-05	CcSEcCtD
Fluvoxamine—Erythema multiforme—Topiramate—epilepsy syndrome	1.03e-05	7.73e-05	CcSEcCtD
Fluvoxamine—Angioedema—Gabapentin—epilepsy syndrome	1.03e-05	7.73e-05	CcSEcCtD
Fluvoxamine—Hypersensitivity—Lamotrigine—epilepsy syndrome	1.03e-05	7.72e-05	CcSEcCtD
Fluvoxamine—Vomiting—Felbamate—epilepsy syndrome	1.03e-05	7.71e-05	CcSEcCtD
Fluvoxamine—Dry mouth—Pregabalin—epilepsy syndrome	1.02e-05	7.68e-05	CcSEcCtD
Fluvoxamine—Pruritus—Carbamazepine—epilepsy syndrome	1.02e-05	7.67e-05	CcSEcCtD
Fluvoxamine—Rash—Felbamate—epilepsy syndrome	1.02e-05	7.64e-05	CcSEcCtD
Fluvoxamine—Eye disorder—Topiramate—epilepsy syndrome	1.02e-05	7.64e-05	CcSEcCtD
Fluvoxamine—Dermatitis—Felbamate—epilepsy syndrome	1.02e-05	7.64e-05	CcSEcCtD
Fluvoxamine—Malaise—Gabapentin—epilepsy syndrome	1.02e-05	7.63e-05	CcSEcCtD
Fluvoxamine—Tinnitus—Topiramate—epilepsy syndrome	1.02e-05	7.62e-05	CcSEcCtD
Fluvoxamine—Vertigo—Gabapentin—epilepsy syndrome	1.01e-05	7.6e-05	CcSEcCtD
Fluvoxamine—Headache—Felbamate—epilepsy syndrome	1.01e-05	7.59e-05	CcSEcCtD
Fluvoxamine—Confusional state—Pregabalin—epilepsy syndrome	1.01e-05	7.59e-05	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	1.01e-05	7.59e-05	CcSEcCtD
Fluvoxamine—Cardiac disorder—Topiramate—epilepsy syndrome	1.01e-05	7.59e-05	CcSEcCtD
Fluvoxamine—Syncope—Gabapentin—epilepsy syndrome	1.01e-05	7.59e-05	CcSEcCtD
Fluvoxamine—Leukopenia—Gabapentin—epilepsy syndrome	1.01e-05	7.57e-05	CcSEcCtD
Fluvoxamine—Dizziness—Clonazepam—epilepsy syndrome	1.01e-05	7.56e-05	CcSEcCtD
Fluvoxamine—Nausea—Vigabatrin—epilepsy syndrome	1.01e-05	7.56e-05	CcSEcCtD
Fluvoxamine—Vomiting—Zonisamide—epilepsy syndrome	1.01e-05	7.54e-05	CcSEcCtD
Fluvoxamine—Insomnia—Valproic Acid—epilepsy syndrome	1e-05	7.53e-05	CcSEcCtD
Fluvoxamine—Oedema—Pregabalin—epilepsy syndrome	1e-05	7.53e-05	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Pregabalin—epilepsy syndrome	1e-05	7.53e-05	CcSEcCtD
Fluvoxamine—Asthenia—Lamotrigine—epilepsy syndrome	1e-05	7.52e-05	CcSEcCtD
Fluvoxamine—Dizziness—Phenytoin—epilepsy syndrome	1e-05	7.51e-05	CcSEcCtD
Fluvoxamine—Rash—Zonisamide—epilepsy syndrome	9.98e-06	7.48e-05	CcSEcCtD
Fluvoxamine—Infection—Pregabalin—epilepsy syndrome	9.97e-06	7.48e-05	CcSEcCtD
Fluvoxamine—Paraesthesia—Valproic Acid—epilepsy syndrome	9.97e-06	7.48e-05	CcSEcCtD
Fluvoxamine—Palpitations—Gabapentin—epilepsy syndrome	9.97e-06	7.47e-05	CcSEcCtD
Fluvoxamine—Dermatitis—Zonisamide—epilepsy syndrome	9.97e-06	7.47e-05	CcSEcCtD
Fluvoxamine—Dizziness—Oxcarbazepine—epilepsy syndrome	9.96e-06	7.47e-05	CcSEcCtD
Fluvoxamine—Nausea—Diazepam—epilepsy syndrome	9.92e-06	7.44e-05	CcSEcCtD
Fluvoxamine—Loss of consciousness—Gabapentin—epilepsy syndrome	9.91e-06	7.43e-05	CcSEcCtD
Fluvoxamine—Headache—Zonisamide—epilepsy syndrome	9.91e-06	7.43e-05	CcSEcCtD
Fluvoxamine—Dyspnoea—Valproic Acid—epilepsy syndrome	9.9e-06	7.42e-05	CcSEcCtD
Fluvoxamine—Diarrhoea—Carbamazepine—epilepsy syndrome	9.89e-06	7.42e-05	CcSEcCtD
Fluvoxamine—Angiopathy—Topiramate—epilepsy syndrome	9.89e-06	7.42e-05	CcSEcCtD
Fluvoxamine—Pruritus—Lamotrigine—epilepsy syndrome	9.89e-06	7.41e-05	CcSEcCtD
Fluvoxamine—Shock—Pregabalin—epilepsy syndrome	9.88e-06	7.41e-05	CcSEcCtD
Fluvoxamine—Somnolence—Valproic Acid—epilepsy syndrome	9.87e-06	7.4e-05	CcSEcCtD
Fluvoxamine—Nervous system disorder—Pregabalin—epilepsy syndrome	9.84e-06	7.38e-05	CcSEcCtD
Fluvoxamine—Cough—Gabapentin—epilepsy syndrome	9.84e-06	7.38e-05	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Pregabalin—epilepsy syndrome	9.83e-06	7.37e-05	CcSEcCtD
Fluvoxamine—Tachycardia—Pregabalin—epilepsy syndrome	9.8e-06	7.35e-05	CcSEcCtD
Fluvoxamine—Chills—Topiramate—epilepsy syndrome	9.78e-06	7.33e-05	CcSEcCtD
Fluvoxamine—Dyspepsia—Valproic Acid—epilepsy syndrome	9.77e-06	7.33e-05	CcSEcCtD
Fluvoxamine—Convulsion—Gabapentin—epilepsy syndrome	9.77e-06	7.33e-05	CcSEcCtD
Fluvoxamine—Hypertension—Gabapentin—epilepsy syndrome	9.74e-06	7.3e-05	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Pregabalin—epilepsy syndrome	9.7e-06	7.28e-05	CcSEcCtD
Fluvoxamine—Vomiting—Clonazepam—epilepsy syndrome	9.69e-06	7.27e-05	CcSEcCtD
Fluvoxamine—Decreased appetite—Valproic Acid—epilepsy syndrome	9.65e-06	7.24e-05	CcSEcCtD
Fluvoxamine—Alopecia—Topiramate—epilepsy syndrome	9.63e-06	7.22e-05	CcSEcCtD
Fluvoxamine—Vomiting—Phenytoin—epilepsy syndrome	9.63e-06	7.22e-05	CcSEcCtD
Fluvoxamine—Rash—Clonazepam—epilepsy syndrome	9.61e-06	7.21e-05	CcSEcCtD
Fluvoxamine—Dermatitis—Clonazepam—epilepsy syndrome	9.6e-06	7.2e-05	CcSEcCtD
Fluvoxamine—Myalgia—Gabapentin—epilepsy syndrome	9.6e-06	7.2e-05	CcSEcCtD
Fluvoxamine—Chest pain—Gabapentin—epilepsy syndrome	9.6e-06	7.2e-05	CcSEcCtD
Fluvoxamine—Arthralgia—Gabapentin—epilepsy syndrome	9.6e-06	7.2e-05	CcSEcCtD
Fluvoxamine—Nausea—Felbamate—epilepsy syndrome	9.6e-06	7.2e-05	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	9.59e-06	7.19e-05	CcSEcCtD
Fluvoxamine—Vomiting—Oxcarbazepine—epilepsy syndrome	9.58e-06	7.18e-05	CcSEcCtD
Fluvoxamine—Fatigue—Valproic Acid—epilepsy syndrome	9.57e-06	7.18e-05	CcSEcCtD
Fluvoxamine—Anxiety—Gabapentin—epilepsy syndrome	9.57e-06	7.18e-05	CcSEcCtD
Fluvoxamine—Anorexia—Pregabalin—epilepsy syndrome	9.57e-06	7.18e-05	CcSEcCtD
Fluvoxamine—Dizziness—Carbamazepine—epilepsy syndrome	9.56e-06	7.17e-05	CcSEcCtD
Fluvoxamine—Diarrhoea—Lamotrigine—epilepsy syndrome	9.56e-06	7.17e-05	CcSEcCtD
Fluvoxamine—Headache—Clonazepam—epilepsy syndrome	9.55e-06	7.16e-05	CcSEcCtD
Fluvoxamine—Rash—Phenytoin—epilepsy syndrome	9.55e-06	7.16e-05	CcSEcCtD
Fluvoxamine—Mental disorder—Topiramate—epilepsy syndrome	9.55e-06	7.16e-05	CcSEcCtD
Fluvoxamine—Dermatitis—Phenytoin—epilepsy syndrome	9.54e-06	7.16e-05	CcSEcCtD
Fluvoxamine—Rash—Oxcarbazepine—epilepsy syndrome	9.5e-06	7.12e-05	CcSEcCtD
Fluvoxamine—Constipation—Valproic Acid—epilepsy syndrome	9.49e-06	7.12e-05	CcSEcCtD
Fluvoxamine—Pain—Valproic Acid—epilepsy syndrome	9.49e-06	7.12e-05	CcSEcCtD
Fluvoxamine—Dermatitis—Oxcarbazepine—epilepsy syndrome	9.49e-06	7.12e-05	CcSEcCtD
Fluvoxamine—Headache—Phenytoin—epilepsy syndrome	9.49e-06	7.12e-05	CcSEcCtD
Fluvoxamine—Malnutrition—Topiramate—epilepsy syndrome	9.49e-06	7.12e-05	CcSEcCtD
Fluvoxamine—Discomfort—Gabapentin—epilepsy syndrome	9.49e-06	7.11e-05	CcSEcCtD
Fluvoxamine—Headache—Oxcarbazepine—epilepsy syndrome	9.44e-06	7.08e-05	CcSEcCtD
Fluvoxamine—Nausea—Zonisamide—epilepsy syndrome	9.4e-06	7.05e-05	CcSEcCtD
Fluvoxamine—Dry mouth—Gabapentin—epilepsy syndrome	9.39e-06	7.04e-05	CcSEcCtD
Fluvoxamine—Hypotension—Pregabalin—epilepsy syndrome	9.38e-06	7.03e-05	CcSEcCtD
Fluvoxamine—Flatulence—Topiramate—epilepsy syndrome	9.35e-06	7.01e-05	CcSEcCtD
Fluvoxamine—Tension—Topiramate—epilepsy syndrome	9.31e-06	6.98e-05	CcSEcCtD
Fluvoxamine—Dysgeusia—Topiramate—epilepsy syndrome	9.29e-06	6.97e-05	CcSEcCtD
Fluvoxamine—Confusional state—Gabapentin—epilepsy syndrome	9.28e-06	6.96e-05	CcSEcCtD
Fluvoxamine—Dizziness—Lamotrigine—epilepsy syndrome	9.24e-06	6.93e-05	CcSEcCtD
Fluvoxamine—Nervousness—Topiramate—epilepsy syndrome	9.22e-06	6.91e-05	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Gabapentin—epilepsy syndrome	9.2e-06	6.9e-05	CcSEcCtD
Fluvoxamine—Oedema—Gabapentin—epilepsy syndrome	9.2e-06	6.9e-05	CcSEcCtD
Fluvoxamine—Vomiting—Carbamazepine—epilepsy syndrome	9.19e-06	6.89e-05	CcSEcCtD
Fluvoxamine—Back pain—Topiramate—epilepsy syndrome	9.18e-06	6.88e-05	CcSEcCtD
Fluvoxamine—Feeling abnormal—Valproic Acid—epilepsy syndrome	9.15e-06	6.86e-05	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	9.14e-06	6.86e-05	CcSEcCtD
Fluvoxamine—Infection—Gabapentin—epilepsy syndrome	9.14e-06	6.86e-05	CcSEcCtD
Fluvoxamine—Muscle spasms—Topiramate—epilepsy syndrome	9.12e-06	6.84e-05	CcSEcCtD
Fluvoxamine—Rash—Carbamazepine—epilepsy syndrome	9.12e-06	6.84e-05	CcSEcCtD
Fluvoxamine—Dermatitis—Carbamazepine—epilepsy syndrome	9.11e-06	6.83e-05	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	9.08e-06	6.81e-05	CcSEcCtD
Fluvoxamine—Insomnia—Pregabalin—epilepsy syndrome	9.08e-06	6.81e-05	CcSEcCtD
Fluvoxamine—Nausea—Clonazepam—epilepsy syndrome	9.06e-06	6.79e-05	CcSEcCtD
Fluvoxamine—Headache—Carbamazepine—epilepsy syndrome	9.06e-06	6.79e-05	CcSEcCtD
Fluvoxamine—Shock—Gabapentin—epilepsy syndrome	9.06e-06	6.79e-05	CcSEcCtD
Fluvoxamine—Nervous system disorder—Gabapentin—epilepsy syndrome	9.03e-06	6.77e-05	CcSEcCtD
Fluvoxamine—Paraesthesia—Pregabalin—epilepsy syndrome	9.01e-06	6.76e-05	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Gabapentin—epilepsy syndrome	9.01e-06	6.76e-05	CcSEcCtD
Fluvoxamine—Nausea—Phenytoin—epilepsy syndrome	9e-06	6.75e-05	CcSEcCtD
Fluvoxamine—Tachycardia—Gabapentin—epilepsy syndrome	8.98e-06	6.74e-05	CcSEcCtD
Fluvoxamine—Dyspnoea—Pregabalin—epilepsy syndrome	8.95e-06	6.71e-05	CcSEcCtD
Fluvoxamine—Nausea—Oxcarbazepine—epilepsy syndrome	8.95e-06	6.71e-05	CcSEcCtD
Fluvoxamine—Vision blurred—Topiramate—epilepsy syndrome	8.94e-06	6.71e-05	CcSEcCtD
Fluvoxamine—Somnolence—Pregabalin—epilepsy syndrome	8.92e-06	6.69e-05	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Gabapentin—epilepsy syndrome	8.9e-06	6.67e-05	CcSEcCtD
Fluvoxamine—Tremor—Topiramate—epilepsy syndrome	8.89e-06	6.67e-05	CcSEcCtD
Fluvoxamine—Vomiting—Lamotrigine—epilepsy syndrome	8.88e-06	6.66e-05	CcSEcCtD
Fluvoxamine—Urticaria—Valproic Acid—epilepsy syndrome	8.82e-06	6.62e-05	CcSEcCtD
Fluvoxamine—Rash—Lamotrigine—epilepsy syndrome	8.81e-06	6.61e-05	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Topiramate—epilepsy syndrome	8.8e-06	6.6e-05	CcSEcCtD
Fluvoxamine—Dermatitis—Lamotrigine—epilepsy syndrome	8.8e-06	6.6e-05	CcSEcCtD
Fluvoxamine—Abdominal pain—Valproic Acid—epilepsy syndrome	8.78e-06	6.58e-05	CcSEcCtD
Fluvoxamine—Body temperature increased—Valproic Acid—epilepsy syndrome	8.78e-06	6.58e-05	CcSEcCtD
Fluvoxamine—Anorexia—Gabapentin—epilepsy syndrome	8.77e-06	6.58e-05	CcSEcCtD
Fluvoxamine—Anaemia—Topiramate—epilepsy syndrome	8.77e-06	6.58e-05	CcSEcCtD
Fluvoxamine—Headache—Lamotrigine—epilepsy syndrome	8.75e-06	6.56e-05	CcSEcCtD
Fluvoxamine—Decreased appetite—Pregabalin—epilepsy syndrome	8.73e-06	6.54e-05	CcSEcCtD
Fluvoxamine—Agitation—Topiramate—epilepsy syndrome	8.72e-06	6.54e-05	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	8.67e-06	6.5e-05	CcSEcCtD
Fluvoxamine—Fatigue—Pregabalin—epilepsy syndrome	8.65e-06	6.49e-05	CcSEcCtD
Fluvoxamine—Hypotension—Gabapentin—epilepsy syndrome	8.6e-06	6.45e-05	CcSEcCtD
Fluvoxamine—Nausea—Carbamazepine—epilepsy syndrome	8.59e-06	6.44e-05	CcSEcCtD
Fluvoxamine—Constipation—Pregabalin—epilepsy syndrome	8.58e-06	6.44e-05	CcSEcCtD
Fluvoxamine—Pain—Pregabalin—epilepsy syndrome	8.58e-06	6.44e-05	CcSEcCtD
Fluvoxamine—Malaise—Topiramate—epilepsy syndrome	8.56e-06	6.42e-05	CcSEcCtD
Fluvoxamine—Vertigo—Topiramate—epilepsy syndrome	8.52e-06	6.39e-05	CcSEcCtD
Fluvoxamine—Syncope—Topiramate—epilepsy syndrome	8.51e-06	6.38e-05	CcSEcCtD
Fluvoxamine—Leukopenia—Topiramate—epilepsy syndrome	8.49e-06	6.37e-05	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	8.39e-06	6.29e-05	CcSEcCtD
Fluvoxamine—Palpitations—Topiramate—epilepsy syndrome	8.38e-06	6.29e-05	CcSEcCtD
Fluvoxamine—Loss of consciousness—Topiramate—epilepsy syndrome	8.34e-06	6.25e-05	CcSEcCtD
Fluvoxamine—Insomnia—Gabapentin—epilepsy syndrome	8.32e-06	6.24e-05	CcSEcCtD
Fluvoxamine—Nausea—Lamotrigine—epilepsy syndrome	8.3e-06	6.22e-05	CcSEcCtD
Fluvoxamine—Cough—Topiramate—epilepsy syndrome	8.28e-06	6.21e-05	CcSEcCtD
Fluvoxamine—Feeling abnormal—Pregabalin—epilepsy syndrome	8.27e-06	6.2e-05	CcSEcCtD
Fluvoxamine—Paraesthesia—Gabapentin—epilepsy syndrome	8.26e-06	6.2e-05	CcSEcCtD
Fluvoxamine—Convulsion—Topiramate—epilepsy syndrome	8.22e-06	6.17e-05	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	8.21e-06	6.16e-05	CcSEcCtD
Fluvoxamine—Dyspnoea—Gabapentin—epilepsy syndrome	8.21e-06	6.15e-05	CcSEcCtD
Fluvoxamine—Hypertension—Topiramate—epilepsy syndrome	8.19e-06	6.14e-05	CcSEcCtD
Fluvoxamine—Somnolence—Gabapentin—epilepsy syndrome	8.18e-06	6.14e-05	CcSEcCtD
Fluvoxamine—Hypersensitivity—Valproic Acid—epilepsy syndrome	8.18e-06	6.13e-05	CcSEcCtD
Fluvoxamine—Dyspepsia—Gabapentin—epilepsy syndrome	8.1e-06	6.08e-05	CcSEcCtD
Fluvoxamine—Chest pain—Topiramate—epilepsy syndrome	8.08e-06	6.06e-05	CcSEcCtD
Fluvoxamine—Arthralgia—Topiramate—epilepsy syndrome	8.08e-06	6.06e-05	CcSEcCtD
Fluvoxamine—Myalgia—Topiramate—epilepsy syndrome	8.08e-06	6.06e-05	CcSEcCtD
Fluvoxamine—Anxiety—Topiramate—epilepsy syndrome	8.05e-06	6.04e-05	CcSEcCtD
Fluvoxamine—Decreased appetite—Gabapentin—epilepsy syndrome	8e-06	6e-05	CcSEcCtD
Fluvoxamine—Discomfort—Topiramate—epilepsy syndrome	7.98e-06	5.99e-05	CcSEcCtD
Fluvoxamine—Urticaria—Pregabalin—epilepsy syndrome	7.97e-06	5.98e-05	CcSEcCtD
Fluvoxamine—Asthenia—Valproic Acid—epilepsy syndrome	7.97e-06	5.97e-05	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	7.95e-06	5.96e-05	CcSEcCtD
Fluvoxamine—Fatigue—Gabapentin—epilepsy syndrome	7.94e-06	5.95e-05	CcSEcCtD
Fluvoxamine—Abdominal pain—Pregabalin—epilepsy syndrome	7.93e-06	5.95e-05	CcSEcCtD
Fluvoxamine—Body temperature increased—Pregabalin—epilepsy syndrome	7.93e-06	5.95e-05	CcSEcCtD
Fluvoxamine—Dry mouth—Topiramate—epilepsy syndrome	7.9e-06	5.92e-05	CcSEcCtD
Fluvoxamine—Pain—Gabapentin—epilepsy syndrome	7.87e-06	5.9e-05	CcSEcCtD
Fluvoxamine—Constipation—Gabapentin—epilepsy syndrome	7.87e-06	5.9e-05	CcSEcCtD
Fluvoxamine—Pruritus—Valproic Acid—epilepsy syndrome	7.86e-06	5.89e-05	CcSEcCtD
Fluvoxamine—Confusional state—Topiramate—epilepsy syndrome	7.81e-06	5.86e-05	CcSEcCtD
Fluvoxamine—Oedema—Topiramate—epilepsy syndrome	7.74e-06	5.81e-05	CcSEcCtD
Fluvoxamine—Infection—Topiramate—epilepsy syndrome	7.69e-06	5.77e-05	CcSEcCtD
Fluvoxamine—Shock—Topiramate—epilepsy syndrome	7.62e-06	5.71e-05	CcSEcCtD
Fluvoxamine—Diarrhoea—Valproic Acid—epilepsy syndrome	7.6e-06	5.7e-05	CcSEcCtD
Fluvoxamine—Nervous system disorder—Topiramate—epilepsy syndrome	7.59e-06	5.7e-05	CcSEcCtD
Fluvoxamine—Feeling abnormal—Gabapentin—epilepsy syndrome	7.58e-06	5.69e-05	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Topiramate—epilepsy syndrome	7.58e-06	5.69e-05	CcSEcCtD
Fluvoxamine—Tachycardia—Topiramate—epilepsy syndrome	7.56e-06	5.67e-05	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	7.53e-06	5.64e-05	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Topiramate—epilepsy syndrome	7.49e-06	5.61e-05	CcSEcCtD
Fluvoxamine—Hypersensitivity—Pregabalin—epilepsy syndrome	7.4e-06	5.55e-05	CcSEcCtD
Fluvoxamine—Anorexia—Topiramate—epilepsy syndrome	7.38e-06	5.54e-05	CcSEcCtD
Fluvoxamine—Dizziness—Valproic Acid—epilepsy syndrome	7.34e-06	5.51e-05	CcSEcCtD
Fluvoxamine—Urticaria—Gabapentin—epilepsy syndrome	7.31e-06	5.48e-05	CcSEcCtD
Fluvoxamine—Body temperature increased—Gabapentin—epilepsy syndrome	7.28e-06	5.46e-05	CcSEcCtD
Fluvoxamine—Abdominal pain—Gabapentin—epilepsy syndrome	7.28e-06	5.46e-05	CcSEcCtD
Fluvoxamine—Hypotension—Topiramate—epilepsy syndrome	7.24e-06	5.43e-05	CcSEcCtD
Fluvoxamine—Asthenia—Pregabalin—epilepsy syndrome	7.2e-06	5.4e-05	CcSEcCtD
Fluvoxamine—Pruritus—Pregabalin—epilepsy syndrome	7.1e-06	5.33e-05	CcSEcCtD
Fluvoxamine—Vomiting—Valproic Acid—epilepsy syndrome	7.06e-06	5.29e-05	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	7.05e-06	5.29e-05	CcSEcCtD
Fluvoxamine—Insomnia—Topiramate—epilepsy syndrome	7e-06	5.25e-05	CcSEcCtD
Fluvoxamine—Rash—Valproic Acid—epilepsy syndrome	7e-06	5.25e-05	CcSEcCtD
Fluvoxamine—Dermatitis—Valproic Acid—epilepsy syndrome	6.99e-06	5.25e-05	CcSEcCtD
Fluvoxamine—Headache—Valproic Acid—epilepsy syndrome	6.96e-06	5.22e-05	CcSEcCtD
Fluvoxamine—Paraesthesia—Topiramate—epilepsy syndrome	6.95e-06	5.21e-05	CcSEcCtD
Fluvoxamine—Dyspnoea—Topiramate—epilepsy syndrome	6.9e-06	5.18e-05	CcSEcCtD
Fluvoxamine—Somnolence—Topiramate—epilepsy syndrome	6.88e-06	5.16e-05	CcSEcCtD
Fluvoxamine—Diarrhoea—Pregabalin—epilepsy syndrome	6.87e-06	5.15e-05	CcSEcCtD
Fluvoxamine—Dyspepsia—Topiramate—epilepsy syndrome	6.82e-06	5.11e-05	CcSEcCtD
Fluvoxamine—Hypersensitivity—Gabapentin—epilepsy syndrome	6.78e-06	5.09e-05	CcSEcCtD
Fluvoxamine—Decreased appetite—Topiramate—epilepsy syndrome	6.73e-06	5.05e-05	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	6.69e-06	5.01e-05	CcSEcCtD
Fluvoxamine—Fatigue—Topiramate—epilepsy syndrome	6.68e-06	5.01e-05	CcSEcCtD
Fluvoxamine—Dizziness—Pregabalin—epilepsy syndrome	6.64e-06	4.98e-05	CcSEcCtD
Fluvoxamine—Constipation—Topiramate—epilepsy syndrome	6.62e-06	4.97e-05	CcSEcCtD
Fluvoxamine—Pain—Topiramate—epilepsy syndrome	6.62e-06	4.97e-05	CcSEcCtD
Fluvoxamine—Asthenia—Gabapentin—epilepsy syndrome	6.6e-06	4.95e-05	CcSEcCtD
Fluvoxamine—Nausea—Valproic Acid—epilepsy syndrome	6.59e-06	4.95e-05	CcSEcCtD
Fluvoxamine—Pruritus—Gabapentin—epilepsy syndrome	6.51e-06	4.88e-05	CcSEcCtD
Fluvoxamine—Vomiting—Pregabalin—epilepsy syndrome	6.38e-06	4.79e-05	CcSEcCtD
Fluvoxamine—Feeling abnormal—Topiramate—epilepsy syndrome	6.38e-06	4.79e-05	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Topiramate—epilepsy syndrome	6.33e-06	4.75e-05	CcSEcCtD
Fluvoxamine—Rash—Pregabalin—epilepsy syndrome	6.33e-06	4.75e-05	CcSEcCtD
Fluvoxamine—Dermatitis—Pregabalin—epilepsy syndrome	6.32e-06	4.74e-05	CcSEcCtD
Fluvoxamine—Diarrhoea—Gabapentin—epilepsy syndrome	6.3e-06	4.72e-05	CcSEcCtD
Fluvoxamine—Headache—Pregabalin—epilepsy syndrome	6.29e-06	4.72e-05	CcSEcCtD
Fluvoxamine—Urticaria—Topiramate—epilepsy syndrome	6.15e-06	4.61e-05	CcSEcCtD
Fluvoxamine—Abdominal pain—Topiramate—epilepsy syndrome	6.12e-06	4.59e-05	CcSEcCtD
Fluvoxamine—Body temperature increased—Topiramate—epilepsy syndrome	6.12e-06	4.59e-05	CcSEcCtD
Fluvoxamine—Dizziness—Gabapentin—epilepsy syndrome	6.09e-06	4.56e-05	CcSEcCtD
Fluvoxamine—Nausea—Pregabalin—epilepsy syndrome	5.96e-06	4.47e-05	CcSEcCtD
Fluvoxamine—Vomiting—Gabapentin—epilepsy syndrome	5.85e-06	4.39e-05	CcSEcCtD
Fluvoxamine—Rash—Gabapentin—epilepsy syndrome	5.8e-06	4.35e-05	CcSEcCtD
Fluvoxamine—Dermatitis—Gabapentin—epilepsy syndrome	5.8e-06	4.35e-05	CcSEcCtD
Fluvoxamine—Headache—Gabapentin—epilepsy syndrome	5.77e-06	4.32e-05	CcSEcCtD
Fluvoxamine—Hypersensitivity—Topiramate—epilepsy syndrome	5.71e-06	4.28e-05	CcSEcCtD
Fluvoxamine—Asthenia—Topiramate—epilepsy syndrome	5.56e-06	4.17e-05	CcSEcCtD
Fluvoxamine—Pruritus—Topiramate—epilepsy syndrome	5.48e-06	4.11e-05	CcSEcCtD
Fluvoxamine—Nausea—Gabapentin—epilepsy syndrome	5.47e-06	4.1e-05	CcSEcCtD
Fluvoxamine—Diarrhoea—Topiramate—epilepsy syndrome	5.3e-06	3.97e-05	CcSEcCtD
Fluvoxamine—Dizziness—Topiramate—epilepsy syndrome	5.12e-06	3.84e-05	CcSEcCtD
Fluvoxamine—Vomiting—Topiramate—epilepsy syndrome	4.92e-06	3.69e-05	CcSEcCtD
Fluvoxamine—Rash—Topiramate—epilepsy syndrome	4.88e-06	3.66e-05	CcSEcCtD
Fluvoxamine—Dermatitis—Topiramate—epilepsy syndrome	4.88e-06	3.66e-05	CcSEcCtD
Fluvoxamine—Headache—Topiramate—epilepsy syndrome	4.85e-06	3.64e-05	CcSEcCtD
Fluvoxamine—Nausea—Topiramate—epilepsy syndrome	4.6e-06	3.45e-05	CcSEcCtD
Fluvoxamine—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	2.91e-06	8.88e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—AQP1—epilepsy syndrome	2.89e-06	8.84e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—AQP1—epilepsy syndrome	2.87e-06	8.77e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	2.86e-06	8.75e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—NEU1—epilepsy syndrome	2.86e-06	8.73e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—UPB1—epilepsy syndrome	2.86e-06	8.73e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ATIC—epilepsy syndrome	2.86e-06	8.73e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	2.84e-06	8.69e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	2.84e-06	8.69e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ABCG2—epilepsy syndrome	2.83e-06	8.66e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	2.81e-06	8.58e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ADSL—epilepsy syndrome	2.8e-06	8.57e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CHRM3—epilepsy syndrome	2.78e-06	8.49e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	2.78e-06	8.49e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CYP2C19—epilepsy syndrome	2.76e-06	8.44e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.75e-06	8.42e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GLUL—epilepsy syndrome	2.75e-06	8.4e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	2.75e-06	8.4e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CYP11A1—epilepsy syndrome	2.74e-06	8.39e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.73e-06	8.33e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	2.7e-06	8.25e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—HMOX1—epilepsy syndrome	2.7e-06	8.25e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CYP2D6—epilepsy syndrome	2.68e-06	8.2e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—CAT—epilepsy syndrome	2.66e-06	8.14e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GBE1—epilepsy syndrome	2.65e-06	8.11e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	2.65e-06	8.11e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.65e-06	8.1e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CYP2D6—epilepsy syndrome	2.63e-06	8.03e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	2.62e-06	8.01e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	2.62e-06	8e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	2.62e-06	8e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.6e-06	7.93e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	2.59e-06	7.93e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	2.59e-06	7.93e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—ABCB1—epilepsy syndrome	2.59e-06	7.91e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—ADRA2A—epilepsy syndrome	2.55e-06	7.8e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—BCHE—epilepsy syndrome	2.54e-06	7.77e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	2.52e-06	7.72e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—ADRA2A—epilepsy syndrome	2.5e-06	7.64e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	2.5e-06	7.63e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	2.5e-06	7.63e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—BCHE—epilepsy syndrome	2.49e-06	7.61e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—BCHE—epilepsy syndrome	2.49e-06	7.6e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.48e-06	7.59e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CYP2D6—epilepsy syndrome	2.48e-06	7.57e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—AQP1—epilepsy syndrome	2.45e-06	7.49e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	2.43e-06	7.42e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—SLC2A1—epilepsy syndrome	2.43e-06	7.41e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.42e-06	7.38e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—GPX1—epilepsy syndrome	2.41e-06	7.36e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PLCB1—epilepsy syndrome	2.4e-06	7.33e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—TH—epilepsy syndrome	2.39e-06	7.31e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—SLC2A1—epilepsy syndrome	2.38e-06	7.26e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	2.37e-06	7.25e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.37e-06	7.23e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—NT5E—epilepsy syndrome	2.37e-06	7.23e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ALAD—epilepsy syndrome	2.37e-06	7.23e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ADRA2A—epilepsy syndrome	2.36e-06	7.21e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.35e-06	7.19e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PLCB1—epilepsy syndrome	2.35e-06	7.18e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—BCHE—epilepsy syndrome	2.35e-06	7.18e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	2.35e-06	7.17e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—TH—epilepsy syndrome	2.34e-06	7.16e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—TH—epilepsy syndrome	2.34e-06	7.14e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	2.32e-06	7.09e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ABCG2—epilepsy syndrome	2.26e-06	6.92e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	2.26e-06	6.9e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	2.26e-06	6.9e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	2.25e-06	6.86e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—SLC2A1—epilepsy syndrome	2.24e-06	6.85e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.23e-06	6.81e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	2.22e-06	6.77e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	2.22e-06	6.77e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PLCB1—epilepsy syndrome	2.22e-06	6.77e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	2.21e-06	6.75e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—TH—epilepsy syndrome	2.21e-06	6.75e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	2.21e-06	6.74e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	2.19e-06	6.7e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.17e-06	6.64e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ADSL—epilepsy syndrome	2.16e-06	6.61e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	2.13e-06	6.52e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GLUL—epilepsy syndrome	2.12e-06	6.49e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	2.11e-06	6.46e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—AGT—epilepsy syndrome	2.11e-06	6.45e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	2.09e-06	6.39e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	2.08e-06	6.37e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	2.08e-06	6.35e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—APOE—epilepsy syndrome	2.07e-06	6.32e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	2.07e-06	6.31e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.06e-06	6.31e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	2.06e-06	6.3e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	2.05e-06	6.26e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.03e-06	6.21e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.03e-06	6.21e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	2.03e-06	6.19e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.02e-06	6.18e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—HMOX1—epilepsy syndrome	2e-06	6.1e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	1.98e-06	6.05e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CAT—epilepsy syndrome	1.97e-06	6.02e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—HMOX1—epilepsy syndrome	1.95e-06	5.97e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	1.95e-06	5.96e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.95e-06	5.95e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	1.93e-06	5.9e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CAT—epilepsy syndrome	1.93e-06	5.89e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CAT—epilepsy syndrome	1.92e-06	5.88e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—BCHE—epilepsy syndrome	1.92e-06	5.87e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—ABCB1—epilepsy syndrome	1.92e-06	5.85e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.89e-06	5.78e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.89e-06	5.77e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	1.88e-06	5.76e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—ABCB1—epilepsy syndrome	1.88e-06	5.73e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—BCHE—epilepsy syndrome	1.88e-06	5.73e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	1.87e-06	5.72e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.85e-06	5.67e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	1.85e-06	5.65e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—HMOX1—epilepsy syndrome	1.84e-06	5.63e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	1.83e-06	5.6e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CAT—epilepsy syndrome	1.82e-06	5.56e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	1.81e-06	5.54e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	1.81e-06	5.52e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—TH—epilepsy syndrome	1.81e-06	5.52e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	1.79e-06	5.47e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—GPX1—epilepsy syndrome	1.78e-06	5.44e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.78e-06	5.44e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—POMC—epilepsy syndrome	1.78e-06	5.43e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	1.77e-06	5.42e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PLCB1—epilepsy syndrome	1.77e-06	5.41e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ABCB1—epilepsy syndrome	1.77e-06	5.41e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—BCHE—epilepsy syndrome	1.77e-06	5.4e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—TH—epilepsy syndrome	1.76e-06	5.39e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	1.76e-06	5.38e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	1.76e-06	5.38e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—BCHE—epilepsy syndrome	1.75e-06	5.35e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	1.75e-06	5.35e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—GPX1—epilepsy syndrome	1.74e-06	5.33e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—GPX1—epilepsy syndrome	1.74e-06	5.32e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.74e-06	5.31e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.71e-06	5.23e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.71e-06	5.23e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	1.69e-06	5.15e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	1.67e-06	5.11e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	1.67e-06	5.1e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—TH—epilepsy syndrome	1.66e-06	5.08e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	1.65e-06	5.05e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—TH—epilepsy syndrome	1.65e-06	5.03e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GPX1—epilepsy syndrome	1.64e-06	5.02e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.62e-06	4.96e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—ALB—epilepsy syndrome	1.62e-06	4.95e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.58e-06	4.84e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	1.58e-06	4.83e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—AGT—epilepsy syndrome	1.56e-06	4.77e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—APOE—epilepsy syndrome	1.53e-06	4.68e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—AGT—epilepsy syndrome	1.53e-06	4.67e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—AGT—epilepsy syndrome	1.53e-06	4.66e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	1.51e-06	4.61e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	1.5e-06	4.59e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—APOE—epilepsy syndrome	1.5e-06	4.58e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—BCHE—epilepsy syndrome	1.5e-06	4.58e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—APOE—epilepsy syndrome	1.5e-06	4.57e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CAT—epilepsy syndrome	1.49e-06	4.55e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—HMOX1—epilepsy syndrome	1.47e-06	4.5e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CAT—epilepsy syndrome	1.45e-06	4.44e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	1.45e-06	4.42e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—AGT—epilepsy syndrome	1.44e-06	4.41e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	1.43e-06	4.37e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	1.42e-06	4.33e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	1.41e-06	4.32e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—APOE—epilepsy syndrome	1.41e-06	4.32e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—TH—epilepsy syndrome	1.41e-06	4.3e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.39e-06	4.26e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.39e-06	4.24e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.39e-06	4.24e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	1.37e-06	4.2e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.37e-06	4.18e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.36e-06	4.15e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CAT—epilepsy syndrome	1.36e-06	4.15e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.35e-06	4.13e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GPX1—epilepsy syndrome	1.35e-06	4.11e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.33e-06	4.07e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	1.32e-06	4.03e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—POMC—epilepsy syndrome	1.31e-06	4.02e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GPX1—epilepsy syndrome	1.31e-06	4.01e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—POMC—epilepsy syndrome	1.29e-06	3.93e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—POMC—epilepsy syndrome	1.28e-06	3.93e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.24e-06	3.78e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GPX1—epilepsy syndrome	1.23e-06	3.75e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.22e-06	3.73e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—POMC—epilepsy syndrome	1.21e-06	3.71e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—ALB—epilepsy syndrome	1.2e-06	3.66e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—AGT—epilepsy syndrome	1.18e-06	3.61e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	1.17e-06	3.59e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—ALB—epilepsy syndrome	1.17e-06	3.59e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—ALB—epilepsy syndrome	1.17e-06	3.58e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.16e-06	3.55e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CAT—epilepsy syndrome	1.16e-06	3.54e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—APOE—epilepsy syndrome	1.16e-06	3.53e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.16e-06	3.53e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—AGT—epilepsy syndrome	1.15e-06	3.52e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—APOE—epilepsy syndrome	1.13e-06	3.45e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	1.13e-06	3.45e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ALB—epilepsy syndrome	1.11e-06	3.38e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.1e-06	3.37e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.09e-06	3.33e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—TH—epilepsy syndrome	1.09e-06	3.32e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.09e-06	3.32e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—AGT—epilepsy syndrome	1.08e-06	3.29e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.06e-06	3.25e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—APOE—epilepsy syndrome	1.05e-06	3.22e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GPX1—epilepsy syndrome	1.05e-06	3.2e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PTGS2—epilepsy syndrome	1.05e-06	3.2e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PTGS2—epilepsy syndrome	1.03e-06	3.14e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	1.02e-06	3.13e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—POMC—epilepsy syndrome	9.93e-07	3.03e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—POMC—epilepsy syndrome	9.69e-07	2.96e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PTGS2—epilepsy syndrome	9.68e-07	2.96e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—AGT—epilepsy syndrome	9.19e-07	2.81e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—POMC—epilepsy syndrome	9.13e-07	2.79e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	9.07e-07	2.77e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—POMC—epilepsy syndrome	9.06e-07	2.77e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ALB—epilepsy syndrome	9.05e-07	2.77e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—APOE—epilepsy syndrome	9.01e-07	2.75e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CAT—epilepsy syndrome	8.95e-07	2.73e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ALB—epilepsy syndrome	8.84e-07	2.7e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	8.7e-07	2.66e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ALB—epilepsy syndrome	8.33e-07	2.54e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ALB—epilepsy syndrome	8.26e-07	2.52e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	8.09e-07	2.47e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	7.92e-07	2.42e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—POMC—epilepsy syndrome	7.74e-07	2.36e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PTGS2—epilepsy syndrome	7.73e-07	2.36e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	7.29e-07	2.23e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	7.22e-07	2.21e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—AKT1—epilepsy syndrome	7.12e-07	2.18e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—AGT—epilepsy syndrome	7.1e-07	2.17e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ALB—epilepsy syndrome	7.06e-07	2.16e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—APOE—epilepsy syndrome	6.95e-07	2.12e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	6.17e-07	1.89e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—POMC—epilepsy syndrome	5.97e-07	1.83e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ALB—epilepsy syndrome	5.44e-07	1.66e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—AKT1—epilepsy syndrome	5.27e-07	1.61e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—AKT1—epilepsy syndrome	5.16e-07	1.58e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—AKT1—epilepsy syndrome	5.15e-07	1.57e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—AKT1—epilepsy syndrome	4.87e-07	1.49e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	4.76e-07	1.46e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—AKT1—epilepsy syndrome	3.98e-07	1.22e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—AKT1—epilepsy syndrome	3.89e-07	1.19e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	3.66e-07	1.12e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—AKT1—epilepsy syndrome	3.63e-07	1.11e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—AKT1—epilepsy syndrome	3.1e-07	9.48e-06	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.39e-07	7.32e-06	CbGpPWpGaD
